Transaction #22893 · Form 4 · 0001437749-26-032865
Moleculin Biotech, Inc. · Stock award · Options (right to buy)
Moleculin Biotech, Inc. · Transacted October 15, 2026 · Filed October 16, 2026
What does this filing report?
An SEC Form 4 filing for Moleculin Biotech, Inc. records a stock award involving Options (right to buy) on October 15, 2026. The reported quantity was 415,000. The filing date is October 16, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Moleculin Biotech, Inc.
- Company CIK
- 0001659617
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 415,000
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 2,341,335
- Ownership description
- Not reported
- SEC acceptance time
- Oct 16, 2026, 9:00 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- KLEMP WALTER V ↗
CEO and President · Director
CIK 0000938419
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 415,000
- Conversion / exercise price
- 0.3701
- Exercise date
- Not reported
- Expiration date
- October 15, 2036
Filing footnotes & remarks
- F1
- Restricted stock units convert into common stock on a one-for-one basis.
- F2
- Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
- F3
- The stock option/restricted stock unit set forth in this table vests as follows: (i) 50% on grant; and (ii) 50% in 18 equal installments over 18 months.
- F4
- Issued in connection with the reporting person's employment with the Company.
- F5
- Each restricted stock unit represents a contingent right to receive one shares of Company common stock.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.